$312 Million is the total value of Defender Capital, LLC.'s 43 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARWR | Exit | ARROWHEAD PHARMACUTICALS | $0 | – | -6,000 | -100.0% | -0.13% | – |
| PSJ | Exit | INVESCO DYNAMIC SOFTWAREetf | $0 | – | -11,095 | -100.0% | -0.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
| DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
| STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
| FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
| MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
| APPLE INC | 20 | Q3 2023 | 0.6% |
| AMAZON INC COM | 20 | Q3 2023 | 0.4% |
| VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
| COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-18 |
| 13F-HR/A | 2023-05-16 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-07-26 |
| 13F-HR/A | 2022-06-07 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.